Trial record 2 of 51 for:    Open Studies | "Dental Implants"

Evaluation of Osseo-integration After Placement of Dental Implants With Patients Receiving Radiotherapy for Buccopharyngeal Oncology

This study is currently recruiting participants. (see Contacts and Locations)
Verified January 2013 by University Hospital, Ghent
Sponsor:
Information provided by (Responsible Party):
University Hospital, Ghent
ClinicalTrials.gov Identifier:
NCT00313989
First received: April 11, 2006
Last updated: January 29, 2013
Last verified: January 2013
  Purpose

Follow up of implants with patients receiving radiotherapy for buccopharyngeal oncology. Implants will be placed 6 weeks before start of the radiotherapy or at least 3 months after the end of the radiotherapy


Condition Intervention
Dental Implants
Procedure: Evaluation of the success rate of implants

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Evaluation of Osseo-integration After Placement of Dental Implants With Patients Receiving Radiotherapy for Buccopharyngeal Oncology

Further study details as provided by University Hospital, Ghent:

Primary Outcome Measures:
  • Recovering and ingrowing of dental implants [ Time Frame: 4 to 6 months ] [ Designated as safety issue: No ]
  • Success rate of dental implants [ Time Frame: 4 to 6 months ] [ Designated as safety issue: No ]

Estimated Enrollment: 200
Study Start Date: September 2007
Estimated Study Completion Date: August 2013
Estimated Primary Completion Date: August 2013 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Evaluation of implants of patients receiving radiotherapy. Procedure: Evaluation of the success rate of implants
Evaluation of the success rate of implants

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Patients receiving radiotherapy (6 weeks later or at least 3 months before) for buccopharyngeal oncology
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00313989

Contacts
Contact: Hugo De Bruyn, MD, PhD + 32 9 332.40.18 hugo.debruyn@UGent.be

Locations
Belgium
University Hospital Ghent Recruiting
Ghent, Belgium, 9000
Contact: Hugo De Bruyn, MD, PhD    + 32 9 332.40.18    hugo.debruyn@UGent.be   
Principal Investigator: Hugo De Bruyn, MD, PhD         
Sponsors and Collaborators
University Hospital, Ghent
Investigators
Principal Investigator: Hugo De Bruyn, MD, PhD University Hospital, Ghent
  More Information

Additional Information:
No publications provided

Responsible Party: University Hospital, Ghent
ClinicalTrials.gov Identifier: NCT00313989     History of Changes
Other Study ID Numbers: 2006/125
Study First Received: April 11, 2006
Last Updated: January 29, 2013
Health Authority: Belgium: Institutional Review Board

ClinicalTrials.gov processed this record on August 21, 2014